OBJECTIVES: To assess patients' perspective about factors associated with stent choice. BACKGROUND: Drug eluting stents (DES) markedly reduce the risk of repeat percutaneous coronary intervention (PCI), but necessitate a longer duration of dual anti-platelet therapy (DAPT) as compared with bare metal stents (BMS). Thus, understanding patients' perspective about factors associated with stent choice is paramount. METHODS: Patients undergoing angiography rated, on a 10-point scale, the importance (1 = not important, 10 = most important) of avoiding repeat revascularization and avoiding the following potential DAPT drawbacks: bleeding/bruising, more pills/day, medication costs and delaying elective surgery. The factor, or group of factors, that was rated highest by each patient was identified. RESULTS: Among 311 patients, repeat revascularization was the single most important consideration to 14.4% of patients, while 20.6% considered avoiding one of the DAPT drawbacks as most important. Most patients (65%) considered avoiding at least one DAPT drawback as important as avoiding repeat revascularization. In no subgroup of patients did more than a quarter of patients prefer avoiding repeat revascularization above all other concerns. Among patients undergoing PCI, more than three quarters received a DES, regardless of their stated preferences (DES use among those most valuing DES benefits, avoiding DAPT drawbacks, or both equally were 78.7%, 86.2%, and 85.6%, respectively, P = 0.56). CONCLUSION: Most patients reported that avoiding DAPT drawbacks was as important as avoiding repeat revascularization. Eliciting patient preferences regarding stent type can enhance shared decision-making and allow physicians to better tailor stent choice to patients' goals and values. TRIAL REGISTRATION: Developing and Testing a Personalized Evidence-based Shared Decision-making Tool for Stent Selection (DECIDE-PCI). ClinicalTrials.gov Identifier: NCT02046902. URL: https://clinicaltrials.gov/ct2/show/NCT02046902
OBJECTIVES: To assess patients' perspective about factors associated with stent choice. BACKGROUND: Drug eluting stents (DES) markedly reduce the risk of repeat percutaneous coronary intervention (PCI), but necessitate a longer duration of dual anti-platelet therapy (DAPT) as compared with bare metal stents (BMS). Thus, understanding patients' perspective about factors associated with stent choice is paramount. METHODS:Patients undergoing angiography rated, on a 10-point scale, the importance (1 = not important, 10 = most important) of avoiding repeat revascularization and avoiding the following potential DAPT drawbacks: bleeding/bruising, more pills/day, medication costs and delaying elective surgery. The factor, or group of factors, that was rated highest by each patient was identified. RESULTS: Among 311 patients, repeat revascularization was the single most important consideration to 14.4% of patients, while 20.6% considered avoiding one of the DAPT drawbacks as most important. Most patients (65%) considered avoiding at least one DAPT drawback as important as avoiding repeat revascularization. In no subgroup of patients did more than a quarter of patients prefer avoiding repeat revascularization above all other concerns. Among patients undergoing PCI, more than three quarters received a DES, regardless of their stated preferences (DES use among those most valuing DES benefits, avoiding DAPT drawbacks, or both equally were 78.7%, 86.2%, and 85.6%, respectively, P = 0.56). CONCLUSION: Most patients reported that avoiding DAPT drawbacks was as important as avoiding repeat revascularization. Eliciting patient preferences regarding stent type can enhance shared decision-making and allow physicians to better tailor stent choice to patients' goals and values. TRIAL REGISTRATION: Developing and Testing a Personalized Evidence-based Shared Decision-making Tool for Stent Selection (DECIDE-PCI). ClinicalTrials.gov Identifier: NCT02046902. URL: https://clinicaltrials.gov/ct2/show/NCT02046902
Authors: Amit P Amin; John A Spertus; David J Cohen; Adnan Chhatriwalla; Kevin F Kennedy; Katherine Vilain; Adam C Salisbury; Lakshmi Venkitachalam; Sue Min Lai; Laura Mauri; Sharon-Lise T Normand; John S Rumsfeld; John C Messenger; Robert W Yeh Journal: Arch Intern Med Date: 2012-08-13
Authors: John A Spertus; Richard Bach; Charles Bethea; Adnan Chhatriwalla; Jeptha P Curtis; Elizabeth Gialde; Mayra Guerrero; Kensey Gosch; Philip G Jones; Aaron Kugelmass; Bradley M Leonard; Edward J McNulty; Marc Shelton; Henry H Ting; Carole Decker Journal: Am Heart J Date: 2014-11-15 Impact factor: 4.749
Authors: Frederick A Spencer; Manya Prasad; Per O Vandvik; Devin Chetan; Qi Zhou; Gordon Guyatt Journal: Ann Intern Med Date: 2015-07-21 Impact factor: 25.391
Authors: Robert W Yeh; Sharon-Lise T Normand; Robert E Wolf; Philip G Jones; Kalon K L Ho; David J Cohen; Donald E Cutlip; Laura Mauri; Aaron D Kugelmass; Amit P Amin; John A Spertus Journal: Circulation Date: 2011-09-06 Impact factor: 29.690
Authors: Amit P Amin; Alok Bachuwar; Kimberly J Reid; Adnan K Chhatriwalla; Adam C Salisbury; Robert W Yeh; Mikhail Kosiborod; Tracy Y Wang; Karen P Alexander; Kensey Gosch; David J Cohen; John A Spertus; Richard G Bach Journal: J Am Coll Cardiol Date: 2013-03-26 Impact factor: 24.094
Authors: Ronald J Krone; Richard E Shaw; Lloyd W Klein; James C Blankenship; William S Weintraub Journal: Catheter Cardiovasc Interv Date: 2006-11 Impact factor: 2.692
Authors: Gregg W Stone; Stephen G Ellis; David A Cox; James Hermiller; Charles O'Shaughnessy; James Tift Mann; Mark Turco; Ronald Caputo; Patrick Bergin; Joel Greenberg; Jeffrey J Popma; Mary E Russell Journal: N Engl J Med Date: 2004-01-15 Impact factor: 91.245
Authors: Jeffrey W Moses; Martin B Leon; Jeffrey J Popma; Peter J Fitzgerald; David R Holmes; Charles O'Shaughnessy; Ronald P Caputo; Dean J Kereiakes; David O Williams; Paul S Teirstein; Judith L Jaeger; Richard E Kuntz Journal: N Engl J Med Date: 2003-10-02 Impact factor: 91.245
Authors: Floyd J Fowler; Patricia M Gallagher; Julie P W Bynum; Michael J Barry; F Leslie Lucas; Jonathan S Skinner Journal: J Gen Intern Med Date: 2012-02-28 Impact factor: 5.128
Authors: Adnan K Chhatriwalla; Carole Decker; Elizabeth Gialde; Delwyn Catley; Kathy Goggin; Katie Jaschke; Philip Jones; Dave deBronkart; Tony Sun; John A Spertus Journal: Circ Cardiovasc Qual Outcomes Date: 2019-02
Authors: Luke G Terlouw; Adriaan Moelker; Jan Abrahamsen; Stefan Acosta; Olaf J Bakker; Iris Baumgartner; Louis Boyer; Olivier Corcos; Louisa Jd van Dijk; Mansur Duran; Robert H Geelkerken; Giulio Illuminati; Ralph W Jackson; Jussi M Kärkkäinen; Jeroen J Kolkman; Lars Lönn; Maria A Mazzei; Alexandre Nuzzo; Felice Pecoraro; Jan Raupach; Hence Jm Verhagen; Christoph J Zech; Desirée van Noord; Marco J Bruno Journal: United European Gastroenterol J Date: 2020-04-16 Impact factor: 4.623